SCHEMBL16476537

SCHEMBL16476537

NC(=O)OC[C@H](O)Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
PKM P14618 2/20 0.56
CYP2D6 P10635 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
LMNA P02545 2/20 0.54
KDM4E B2RXH2 1/20 0.54
SRR Q9GZT4 3/20 0.51
TRPA1 O75762 1/20 0.47
EPHX1 P07099 1/20 0.47
ALPI P09923 1/20 0.47
PTGS1 P23219 1/20 0.47
XIAP P98170 1/20 0.47
SLC7A5 Q01650 1/20 0.47
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
PSAT1 Q9Y617 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375857 1.00 CYP1A2 (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
SCHEMBL2258396 0.83 LMNA (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
SCHEMBL28108510 0.83 CYP1A2 (0.48) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
SCHEMBL4116706 0.82 TRPA1 (0.47) CYP1A2PKMSRRTRPA1ALPI
Solriamfetol SCHEMBL2739637 0.82 PKM (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
Solriamfetol SCHEMBL30929349 0.82 PKM (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
Solriamfetol SCHEMBL42526 0.82 PKM (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
Solriamfetol SCHEMBL42525 0.82 PKM (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
Solriamfetol SCHEMBL30929348 0.82 PKM (0.56) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1
SCHEMBL28625596 0.81 CA1 (0.58) CYP1A2SMN1; SMN2PKMCYP2D6NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496228-B1 METHODS FOR TREATING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER SK BIOPHARMACEUTICALS CO LTD (KR) 2014-01-15 EP disclosed